107 related articles for article (PubMed ID: 12955572)
1. Translational and clinical studies of target-based cancer therapy.
Saijo N; Nishio K; Tamura T
Int J Clin Oncol; 2003 Aug; 8(4):187-92. PubMed ID: 12955572
[TBL] [Abstract][Full Text] [Related]
2. Strategy for the development of novel anticancer drugs.
Saijo N; Tamura T; Nishio K
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S97-101. PubMed ID: 12856152
[TBL] [Abstract][Full Text] [Related]
3. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
4. Target gene discovery for novel therapeutic agents in cancer treatment.
Ammerpohl O; Tiwari S; Kalthoff H
Methods Mol Biol; 2010; 576():427-45. PubMed ID: 19882275
[TBL] [Abstract][Full Text] [Related]
5. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
6. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
Perry WL; Weitzman A
Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
[TBL] [Abstract][Full Text] [Related]
7. [Design of new protocols. Role of molecular biology units?].
Milano G
Bull Cancer; 2008 Oct; 95(10):1003-5. PubMed ID: 19004733
[TBL] [Abstract][Full Text] [Related]
8. The convergence of cancer prevention and therapy in early-phase clinical drug development.
Abbruzzese JL; Lippman SM
Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
[TBL] [Abstract][Full Text] [Related]
9. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
10. BMS and Exelixis target tumor suppression pathways.
Expert Rev Anticancer Ther; 2001 Aug; 1(2):167. PubMed ID: 12113021
[No Abstract] [Full Text] [Related]
11. Epigenome-derived drugs: recent advances and future perspectives.
Vogiatzi P; Aimola P; Scarano MI; Claudio PP
Drug News Perspect; 2007 Dec; 20(10):627-33. PubMed ID: 18301797
[TBL] [Abstract][Full Text] [Related]
12. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
13. Molecular target-based cancer therapy: tyrosine kinase inhibitors.
Tamura K; Fukuoka M
Int J Clin Oncol; 2003 Aug; 8(4):207-11. PubMed ID: 12955575
[TBL] [Abstract][Full Text] [Related]
14. SRC as a potential therapeutic target in solid tumor oncology.
Gallick GE
Clin Adv Hematol Oncol; 2004 Jul; 2(7):435-7. PubMed ID: 16163218
[No Abstract] [Full Text] [Related]
15. [New anticancer drugs: much ado about nothing?].
Zimmermann S; Betticher D
Rev Med Suisse; 2014 Apr; 10(425):788, 790-3. PubMed ID: 24791424
[TBL] [Abstract][Full Text] [Related]
16. The contemporary drug development process: advances and challenges in preclinical and clinical development.
Garrett MD; Walton MI; McDonald E; Judson I; Workman P
Prog Cell Cycle Res; 2003; 5():145-58. PubMed ID: 14593708
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. [International estimation of molecular target drug].
Fujisaka Y; Saijo N
Nihon Rinsho; 2004 Jul; 62(7):1225-31. PubMed ID: 15283137
[TBL] [Abstract][Full Text] [Related]
19. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
Low PS; Henne WA; Doorneweerd DD
Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
[TBL] [Abstract][Full Text] [Related]
20. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
Kinders R; Parchment RE; Ji J; Kummar S; Murgo AJ; Gutierrez M; Collins J; Rubinstein L; Pickeral O; Steinberg SM; Yang S; Hollingshead M; Chen A; Helman L; Wiltrout R; Simpson M; Tomaszewski JE; Doroshow JH
Mol Interv; 2007 Dec; 7(6):325-34. PubMed ID: 18199854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
